IVAN AKSENTIJEVICH M.D. NPI 1982672937

NPI Details

Ivan Aksentijevich, M.D. is a hematology and oncology internal medicine in Alexandria, VA with 40 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Ivan Aksentijevich, M.D. NPI is 1982672937. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

4660 KENMORE AVE STE 1018
ALEXANDRIA, VA
ZIP 22304-306
Phone: (571) 483-1800
Fax: (703) 823-5723

The NPI 1982672937 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Nephelometry, test method using light (HCPCS:83883)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Protein measurement, serum (HCPCS:84165)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Unclassified drugs (HCPCS:J3490)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Red blood count automated, with additional calculations (HCPCS:85046)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Uric acid level, blood (HCPCS:84550)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 3/8/2006 and was last updated on 11/11/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.